Oral estramustine plus oral etoposide in the treatment of hormone refractory prostate cancer patients: a phase II study with a 5-year follow-up.
暂无分享,去创建一个
L. Dogliotti | O. Bertetto | D. Fontana | F. Porpiglia | M. Tampellini | M. Tucci | A. Berruti | A. Mosca | C. Terrone | G. Gorzegno | G. Fasolis | R. Tarabuzzi | E. Fara | M. De Stefanis